GLO1 and colorectal cancer: For instance, in a mouse xenograft model, GLO1-depleted breast cancers showed increased tumorigenic and metastatic potential and similarly, increased aggressiveness of colorectal cancer patients’ cancer cells inversely correlated with GLO1 activity (85, 86).